Abstract:Paraneoplastic pemphigus is an autoimmune mucocutaneous disease associated with Castleman's tumours, which when surgically removed often result in great improvement of mucocutaneous lesions. An IgG autoantibody against epidermal proteins is often used as a diagnostic marker for disease. Our aim was to ascertain the role of Castleman's tumours in production of the autoantibody and pathogenesis of paraneoplastic pemphigus.We enrolled seven patients with paraneoplastic pemphigus associated with Castleman's disease and assessed the effect of removal of tumours on mucocutaneous lesions in six individuals and on autoantibody titre with indirect immunofluorescence in four patients. We cultured tumour cells from one patient and assayed the secreted autoantibody. Finally, we characterised the gene sequence and expression of the variable region of the immunoglobulin heavy chain (IgV(H)) in tumour B cells from all patients by reverse transcription-PCR, DNA sequencing, and in-situ hybridisation.Cutaneous lesions disappeared within 6-11 weeks after resection of tumours. Mucosal lesions also improved in this period, but lasted for 5-10 months overall. Autoantibody titre decreased and became undetectable within 5-9 weeks in three of four patients assessed. We identified secreted autoantibody, similar to that identified in patients' serum, in cultured tumour cells. The tumour B-cells of the seven patients shared and expressed two rearrangement patterns of complementarity determining region 3 (CDR3) of IgV(H).Secreted autoantibody from Castleman's tumours, which reacts against epidermal proteins, could be an essential factor in the pathogenesis of paraneoplastic pemphigus. We noted clonal rearrangement, resulting in similar variable regions of IgV(H), in tumour B cells isolated from all seven patients. However, whether this pattern is associated with autoimmunity remains to be ascertained.

Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.

Immunoglobulin G4-related Disease with Multiple Organs Involvement Depicted on FDG PET/CT: A Case Report and Literature Review.

[A case of retroperitoneal Castleman's disease with paraneoplastic pemphigus].

Paraneoplastic Pemphigus with Retroperitoneal Castleman's Tumour

A case of paraneoplastic pemphigus with localized Castleman's disease

Paraneoplastic Pemphigus Associated With Castleman Tumor - A Commonly Reported Subtype Of Paraneoplastic Pemphigus In China

A Case of Paraneoplastic Pemphigus Associated with Recurrent Castleman's Disease

18F-FDG PET/CT in Follicular Dendritic Cell Sarcoma With Paraneoplastic Pemphigus as the First Manifestation.

[Paraneoplastic pemphigus with underlying Castleman's disease in a 16-year-old girl]

Clinical and Experimental Study of Paraneoplastic Pemphigus with Castleman's Disease

Castleman Tumor in Association with Paraneopiastic Pemphigus-A Report of 10 Cases

Adrenal Castleman Disease Associated With Paraneoplastic Pemphigus: A Case Report And Literature Review

Paraneoplastic Pemphigus: A Report of Two Cases

[Localized Castleman Disease with Paraneoplastic Pemphigus and Pulmonary Involvement: Clinical Features and Histopathology].

Mesenteric Castleman Disease Misdiagnosed As Lymph Node Metastasis of Rectal Cancer on 18F-FDG PET/CT

Paraneoplastic pemphigus successfully treated with tumor excision and plasmapheresis as well as corticosteroids

68Ga-DOTATATE and 68Ga-Pentixafor PET/CT in a Patient with Castleman Disease of the Retroperitoneum

Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT

Castleman's tumours and production of autoantibody in paraneoplastic pemphigus.

Paraneoplastic Pemphigus Characterized by Polymorphic Oral Mucosal Manifestations-Report of Two Cases